Interacts regularly with FDA staff on premarket medical device submissions.
Kelliann H. Payne
Counsel
Philadelphia
Languages
French
Kelliann Payne's science education and background in the medical device industry allow her to quickly understand emerging medical device technology and informs her current focus on related legal and business issues. Her experience includes the development, regulation, advertising, and litigation of medical devices.
Kelliann drafts premarket submissions for diagnostic and therapeutic medical devices, evaluates and formulates applicable regulatory strategies, and reviews the accuracy of marketing claims. She helps companies in their preclinical and clinical programs and leads due diligence reviews for investments and acquisitions.
Assistant General Counsel at QVC, Inc. from 2013 to 2014, Kelliann counseled internal clients on Food and Drug Administration (FDA) and Federal Trade Commission (FTC) regulations applicable to health, wellness, beauty, and cosmetic products.
As a consultant for the medical device industry, she assisted companies with complex regulatory challenges and strategies for marketing innovative products. Kelliann majored in biology prior to pursuing a career in law.
Practices
Representative Experience
Latest thinking and events
Published Works
Printing for Medicine: An FDA Framework for 3-D Printing for Medical Devices
MD+DIHogan Lovells Events
3D Printing in Life Sciences: Navigating Pitfalls with an Emerging Technology
17 February 2016
Hogan Lovells Publications
New Draft Guidance Outlines FDA’s Proposed Framework to Collect and Use Patient Preference Information in Device Submissions and Labeling
Medical Device AlertPublished Works
FDA Test Drives Its Draft Refuse to Accept Policy for 510(k) Notices
RTA ArticleHogan Lovells Publications
FDA moves to update its refuse to accept policy for 510(k) notices
Medical Device AlertPublished Works
Review of FDA's Highly-Anticipated Draft Guidance on the 510(k) Program
Update MagazineView More
